about
Weather, Chinook, and stroke occurrence.The relevance of living supports on antiplatelet adherence and trial participation: the SPS3 trial.Clinical correlates of infarct shape and volume in lacunar strokes: the Secondary Prevention of Small Subcortical Strokes trial.Detection of occult atrial fibrillation in patients with embolic stroke of uncertain source: a work in progress.Vertebrobasilar ectasia in patients with lacunar stroke: the secondary prevention of small subcortical strokes trial.Should Blood Pressure Targets After Lacunar Stroke Vary by Body Size? The SPS3 Trial.Left Ventricular Geometry on Transthoracic Echocardiogram and Prognosis after Lacunar Stroke: The SPS3 Trial.Can blood pressure be lowered safely in older adults with lacunar stroke? The Secondary Prevention of Small Subcortical Strokes study experience.CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) studyAchieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial.Early life characteristics and late life burden of cerebral small vessel disease in the Lothian Birth Cohort 1936.What is the relationship between type 2 diabetes mellitus status and the neuroradiological correlates of cerebral small vessel disease in adults? Protocol for a systematic review.Current status of antiplatelet agents to prevent stroke.Prevention of deep vein thrombosis and pulmonary embolism in patients with stroke.Post stroke pain: identification, assessment, and therapy.Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.Therapeutic Strategies and Drug Development for Vascular Cognitive ImpairmentTrends in hospital admission for stroke in Calgary.Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017.Traumatic Brain Injury in a Community-Based Cohort of Homeless and Vulnerably Housed Individuals.Suboccipital Decompressive Craniectomy for Cerebellar Infarction: A Systematic Review and Meta-Analysis.Antithrombotic Strategy in Cerebral Venous Thrombosis: Differences Between Neurologist and Hematologist Respondents in a Canadian Survey.Morphological classification of penetrating artery pontine infarcts and association with risk factors and prognosis: The SPS3 trial.Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A single center cohort description with two cases of histological validation.Journal Club: Relationship between carotid arterial properties and cerebral white matter hyperintensities.Relationship between supra-annual trends in influenza rates and stroke occurrence.Rapidly expanding venous intracerebral haemorrhage with spot sign.Rapid Assessment and Treatment of Transient Ischemic Attacks and Minor Stroke in Canadian Emergency Departments: Time for a Paradigm Shift.Dabigatran following acute transient ischemic attack and minor stroke II (DATAS II).Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic StrokeRivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trialAdults With Complex Congenital Heart Disease: Cerebrovascular Considerations for the NeurologistTeaching NeuroImages: middle cerebral artery aneurysm rupture presenting as pure acute subdural hematomaOff-label use of novel anticoagulants for treatment of cerebral venous thrombosis: A Canadian surveyHypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and ChildrenEffectiveness of interventions involving nurses in secondary stroke prevention: A systematic review and meta-analysisValidation of a Novel Telehealth Administration Protocol for the NIH Toolbox-Cognition BatteryRecanalization following Endovascular treatment and imaging of PErfusion, Regional inFarction and atrophy to Understand Stroke Evolution-NA1 (REPERFUSE-NA1)Rate and Prognosis of Brain Ischemia in Patients With Lower-Risk Transient or Persistent Minor Neurologic EventsNeurocognition in Adult Congenital Heart Disease: How to Monitor and Prevent Progressive Decline
P50
Q33425433-AE5F6DBD-4BD7-43F6-ADED-4252F9D18344Q34205773-720F478D-7E42-4453-8C0E-7678329B23BBQ34347755-E9B8509E-343E-4754-B1EE-3173A3D5E28CQ35238187-A34F5C65-D864-40E8-86D6-190C1E3506B0Q35533322-F8856AC8-0218-4EE1-A0E9-D7807D0AC90AQ35661866-4431EBCD-6AAB-44D0-ABCB-6AC70789E2F2Q35688935-2B663851-7FF9-4C76-A573-26B5A6FC97B2Q36092353-C858B3C5-869B-48A0-9696-E6540DF7F06DQ36141942-2370721F-F5AF-4A56-ACD9-69CE11C8FD0EQ36373385-717DCC8A-3771-4DF8-B4E1-F572306B415AQ37361043-DDED010A-916C-4468-8BD8-23312B2795F6Q37589359-83367855-174A-4287-B1CC-C3D7BBAF5179Q37674733-3DC1042A-87FB-43EE-9D55-CC52FA6F2796Q37898337-A8B1B383-F3D9-4AE5-9D4B-95088F6A5F57Q38376000-A18FB297-D06A-4FD3-B904-4E47F145A07AQ38416331-C3AEB885-3D37-4412-BC87-6DB2E2039DBBQ39286909-408E1868-C860-441D-913E-442D8C31A210Q40481981-BE38BC4D-EDBA-44C5-9486-344B5D478F11Q47660182-A8DBEDCF-D33C-4A9A-BB3C-16FAD8036F66Q47661555-5B694314-2AF7-45F1-9739-BE7B0177392AQ47986256-C4011B13-C71E-4D34-A92E-5F34D5D85A12Q48441767-53B11844-0AB1-46A5-BEFF-C7CE0134658EQ48851859-634C29C8-A28A-408C-A839-B371B1CC2177Q49372675-20607A20-4FD9-4502-8696-B771226861B5Q50026086-6926B533-3599-44B1-86B4-DAB6D70CA3D2Q50747748-1B2D63BF-AA22-4B3C-9B9A-9C8BB803162BQ52638099-0C8AA393-DAF6-4A2B-95E5-DF91086C105BQ53368857-B957103B-6942-4028-B204-3844E7921EB9Q53929488-83844A57-E189-4067-9344-030061A2252BQ57158511-6B60B5EA-E1B9-47C8-950F-A2ECC50AA496Q58300662-DE287716-9BC1-4195-8C96-3A96DBD1733DQ64076221-6800B9ED-555F-49C3-B8B5-3D8F3BCE6024Q82645131-7A7F6D77-34D4-49D5-BD75-BD155D62CFE8Q87072934-14FEF862-00C8-4D00-8AFB-B2AC820CBEECQ88581728-BF0F0169-D8D3-4839-A044-38A818B75EF1Q88947593-35AA3CAB-36D0-42AA-B995-31777158C732Q89176418-4B2A555E-6C05-47D3-84A4-2633206F8F80Q89962715-661DCE13-9BE9-437E-8146-1F80BC54F5F1Q90215737-A1E7E94C-DEB6-421F-A1C5-4D800DD70119Q90387078-ACF6CBA3-35F4-4477-8778-BC6502CDA79C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Thalia S Field
@ast
Thalia S Field
@en
Thalia S Field
@es
Thalia S Field
@nl
type
label
Thalia S Field
@ast
Thalia S Field
@en
Thalia S Field
@es
Thalia S Field
@nl
prefLabel
Thalia S Field
@ast
Thalia S Field
@en
Thalia S Field
@es
Thalia S Field
@nl
P106
P1153
8042510100
P31
P496
0000-0002-1176-0633